Evolution of regorafenib from bench to bedside in colorectal cancer: Is it an attractive option or merely a “me too” drug?
Goel, GauravVolume:
Volume 10
Language:
english
Journal:
Cancer Management and Research
DOI:
10.2147/CMAR.S88825
Date:
March, 2018
File:
PDF, 949 KB
english, 2018